October 28, 2025

Insurance Shake-Up: Who Loses Out?

Families nationwide face rising health insurance costs as Affordable Care Act subsidies near expiration, with premiums and deductibles projected to increase amid congressional inaction.

KFF Health News

October 28, 2025

Fewer Loans: Fewer Doctors?

Changes to federal student loan policy reintroduce borrowing caps for graduate and professional education, impacting how future physicians finance medical training.

KFF Health News

October 27, 2025

How Hormones May Influence Tirzepatide Outcomes

Researchers show how reproductive stage and hormone therapy influence weight-loss outcomes in women treated with tirzepatide.

Conexiant

October 27, 2025

Why Open Access May Not Boost Citations

Researchers found that companion open access journals charge high publication fees yet yield fewer citations than traditional journals.

Conexiant

October 24, 2025

Elinzanetant Approved for Menopausal Hot Flashes by FDA

Bayer’s dual neurokinin 1 and 3 receptor antagonist elinzanetant (Lynkuet) reduced the frequency and severity of menopausal vasomotor symptoms in phase 3 OASIS trials, providing a once daily, nonhormonal treatment option for moderate to severe hot flashes.

Conexiant

October 24, 2025

A New Approach to Lowering Cardiovascular Risk?

Researchers evaluated obicetrapib’s effects on lipid levels and cardiovascular outcomes.

Conexiant

October 23, 2025

Waist Loss Only Part of Semaglutide’s Power

Semaglutide lowered cardiovascular events in patients with overweight or obesity without diabetes, independent of weight loss.

Conexiant

October 23, 2025

Is the Estradiol Ring Losing Strength Early?

Patients reported return of vasomotor symptoms before the 3-month mark in real-world use. 

Conexiant

October 22, 2025

Fall Vaccines: What’s New, What’s Not

Updated CDC fall vaccine guidance simplifies covid, flu, and RSV shots with broad access and minimal changes from last year.

KFF Health News